Evidence indicates that NUPR1 promotes GBM cell proliferation, invasion, and resistance to apoptosis and chemotherapy (e.g., TMZ) by activating oncogenic pathways, like PI3K/AKT/mTOR, and regulating autophagy. This evidence concerns the gene MTOR and glioblastoma.